Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.93 USD | -0.54% | -7.84% | +375.37% |
Apr. 23 | Skye Bioscience, Inc.(NasdaqGM:SKYE) added to NASDAQ Transportation Index | CI |
Apr. 12 | Skye Bioscience, Inc.(NasdaqGM:SKYE) added to NASDAQ Composite Index | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 363M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-16.5
x | P/E ratio 2025 * |
-14.8
x | Employees | 11 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.92% |
1 day | -0.54% | ||
1 week | -7.84% | ||
1 month | -17.33% | ||
3 months | +223.25% | ||
6 months | +638.86% | ||
Current year | +375.37% |
Managers | Title | Age | Since |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 18-01-18 |
Director of Finance/CFO | - | 21-10-04 | |
Chief Tech/Sci/R&D Officer | 52 | 22-12-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 20-08-06 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 21-07-21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 23-08-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 12.93 | -0.54% | 37,292 |
24-04-29 | 13 | -.--% | 27,216 |
24-04-26 | 13 | +1.17% | 31,379 |
24-04-25 | 12.85 | -.--% | 58,926 |
24-04-24 | 12.85 | -8.41% | 108,918 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+375.37% | 365M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- EMBI Stock